C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema
Clinical medicine. Blood disorders · 2011
DOI: 10.4137/cmbd.s4090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical medicine. Blood disorders, 2011. Verfasst von Solange Oliveira Rodrigues Valle und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Hereditary angioedema (HAE) is a relatively rare disease characterized by acute episodes of swelling. These swellings can be disfiguring, painful and life-threatening. Since the symptoms occur in different areas and most patients experience a delay in their diagnosis, resulting in unnecessary suffering and dangerous situations. HAE can have a tremendous impact on the quality of life. The major genetic deficiency in this disorder is either an absent or nonfunctional C1INH which regulates the complement, fibrinolitic, kalikrein and plasmin pathways.
Zitieren
APA
Valle, S. O. R., França, A. T., Campos, R. A., & Grumach, A. S. (2011). C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema. Clinical medicine. Blood disorders. https://doi.org/10.4137/cmbd.s4090
Vancouver
Valle SOR, França AT, Campos RA, Grumach AS. C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema. Clinical medicine. Blood disorders. 2011. doi:10.4137/cmbd.s4090
BibTeX
@article{Valle2011,
author = {Valle, Solange Oliveira Rodrigues and França, Alfeu Tavares and Campos, Regis A. and Grumach, Anete Sevciovic},
title = {C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema},
journal = {Clinical medicine. Blood disorders},
year = {2011},
doi = {10.4137/cmbd.s4090}
}
EUVIMED